BEAM
Price
$16.76
Change
+$0.12 (+0.72%)
Updated
Aug 27, 04:11 PM (EDT)
Capitalization
1.68B
75 days until earnings call
ENTA
Price
$8.56
Change
-$0.09 (-1.04%)
Updated
Aug 27, 03:06 PM (EDT)
Capitalization
184.92M
82 days until earnings call
Interact to see
Advertisement

BEAM vs ENTA

Header iconBEAM vs ENTA Comparison
Open Charts BEAM vs ENTABanner chart's image
Beam Therapeutics
Price$16.76
Change+$0.12 (+0.72%)
Volume$1K
Capitalization1.68B
Enanta Pharmaceuticals
Price$8.56
Change-$0.09 (-1.04%)
Volume$156
Capitalization184.92M
BEAM vs ENTA Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. ENTA commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and ENTA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (BEAM: $16.64 vs. ENTA: $8.65)
Brand notoriety: BEAM and ENTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 71% vs. ENTA: 54%
Market capitalization -- BEAM: $1.68B vs. ENTA: $184.92M
BEAM [@Biotechnology] is valued at $1.68B. ENTA’s [@Biotechnology] market capitalization is $184.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileENTA’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • ENTA’s FA Score: 1 green, 4 red.
According to our system of comparison, ENTA is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while ENTA’s TA Score has 7 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 6 bearish.
  • ENTA’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, ENTA is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +1.77% price change this week, while ENTA (@Biotechnology) price change was +3.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.98%. For the same industry, the average monthly price growth was +13.90%, and the average quarterly price growth was +31.04%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

ENTA is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+3.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.68B) has a higher market cap than ENTA($185M). ENTA YTD gains are higher at: 50.435 vs. BEAM (-32.903). ENTA has higher annual earnings (EBITDA): -82.41M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. ENTA (204M). ENTA has less debt than BEAM: ENTA (58M) vs BEAM (155M). ENTA has higher revenues than BEAM: ENTA (64.8M) vs BEAM (60.3M).
BEAMENTABEAM / ENTA
Capitalization1.68B185M910%
EBITDA-414.33M-82.41M503%
Gain YTD-32.90350.435-65%
P/E RatioN/AN/A-
Revenue60.3M64.8M93%
Total Cash1.15B204M564%
Total Debt155M58M267%
FUNDAMENTALS RATINGS
ENTA: Fundamental Ratings
ENTA
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMENTA
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 13 days ago
78%
Bullish Trend 8 days ago
71%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIHEX18.500.05
+0.27%
Calamos Hedged Equity I
ODMAX44.62N/A
N/A
Invesco Developing Markets A
AIGOX36.33N/A
N/A
Alger Growth & Income I-2
NMULX11.29N/A
N/A
Neuberger Berman Multi-Cap Opp I
LSSNX30.24N/A
N/A
Loomis Sayles Small Cap Growth N